Notice2023-07403
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 10, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 68 (Monday, April 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 68 (Monday, April 10, 2023)]
[Notices]
[Page 21200]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-07403]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, NIAMS.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the NATIONAL
INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NIAMS.
Date: May 2-3, 2023.
Closed: May 02, 2023, 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: Porter Neuroscience Research Center, Building 35A, 620/
630, 35 Convent Drive, Bethesda, MD 20892.
Closed: May 03, 2023, 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: Porter Neuroscience Research Center, Building 35A, 620/
630, 35 Convent Drive, Bethesda, MD 20892.
Contact Person: John J. O'Shea, MD, Scientific Director of
Intramural Research, National Institute of Arthritis &
Musculoskeletal and Skin Diseases, Building 10, Bethesda, MD 20892,
(301) 496-2612, <a href="/cdn-cgi/l/email-protection#cca3bfa4a9ada68ca1ada5a0e2a2a5a4e2aba3ba"><span class="__cf_email__" data-cfemail="a6c9d5cec3c7cce6cbc7cfca88c8cfce88c1c9d0">[email protected]</span></a>.
In the interest of security, NIH has procedures at <a href="https://www.nih.gov/about-nih/visitor-information/campus-access-security">https://www.nih.gov/about-nih/visitor-information/campus-access-security</a> for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Additional Health and Safety Guidance: Before attending a
meeting at an NIH facility, it is important that visitors review the
NIH COVID-19 Safety Plan at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx</a> and the NIH testing and
assessment web page at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/visitor-testing-requirement.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/visitor-testing-requirement.aspx</a> for information about requirements and procedures
for entering NIH facilities, especially when COVID-19 community
levels are medium or high. In addition, the Safer Federal Workforce
website has FAQs for visitors at <a href="https://www.saferfederalworkforce.gov/faq/visitors/">https://www.saferfederalworkforce.gov/faq/visitors/</a>. Please note that if an
individual has a COVID-19 diagnosis within 10 days of the meeting,
that person must attend virtually. (For more information please read
NIH's Requirements for Persons after Exposure at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx</a> and What
Happens When Someone Tests Positive at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx</a>. Anyone from the public can attend the open
portion of the meeting virtually via the NIH Videocasting website
(<a href="http://videocast.nih.gov">http://videocast.nih.gov</a>). Please continue checking these websites,
in addition to the committee website listed below, for the most up
to date guidance as the meeting date approaches.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: April 4, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07403 Filed 4-7-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 10, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.